Xponance’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-563
| Closed | -$6.06K | – | 1528 |
|
|
2025
Q1 | $6.06K | Buy |
563
+13
| +2% | +$140 | ﹤0.01% | 1443 |
|
|
2024
Q4 | $7.04K | Buy |
550
+47
| +9% | +$602 | ﹤0.01% | 1442 |
|
|
2024
Q3 | $13.9K | Hold |
503
| – | – | ﹤0.01% | 1386 |
|
|
2024
Q2 | $14.6K | Sell |
503
-31
| -6% | -$898 | ﹤0.01% | 1312 |
|
|
2024
Q1 | $23.8K | Buy |
534
+20
| +4% | +$891 | ﹤0.01% | 1293 |
|
|
2023
Q4 | $19.9K | Hold |
514
| – | – | ﹤0.01% | 1266 |
|
|
2023
Q3 | $15.1K | Buy |
+514
| New | +$15.1K | ﹤0.01% | 1239 |
|